Morningstar Investment Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,245
Closed -$285K 407
2024
Q2
$285K Sell
1,245
-182
-13% -$39.6K ﹤0.01% 319
2024
Q1
$309K Sell
1,427
-429
-23% -$100K ﹤0.01% 284
2023
Q4
$484K Buy
1,856
+1,023
+123% +$251K ﹤0.01% 291
2023
Q3
$215K Sell
833
-42
-5% -$11.2K ﹤0.01% 271
2023
Q2
$247K Buy
+875
New +$260K ﹤0.01% 235
2022
Q3
Sell
-13,537
Closed -$2.78M 220
2022
Q2
$2.78M Sell
13,537
-629
-4% -$129K 0.04% 139
2022
Q1
$2.99M Hold
14,166
0.03% 155
2021
Q4
$3.4M Buy
14,166
+3,125
+28% +$804K 0.04% 148
2021
Q3
$3.15M Buy
11,041
+1,810
+20% +$593K 0.04% 149
2021
Q2
$3.19M Sell
9,231
-15,729
-63% -$4.76M 0.04% 149
2021
Q1
$6.89M Hold
24,960
0.09% 133
2020
Q4
$6.11M Sell
24,960
-438
-2% -$113K 0.09% 133
2020
Q3
$7.17M Hold
25,398
0.11% 125
2020
Q2
$6.61M Buy
+25,398
New +$7.63M 0.11% 126
2019
Q3
Sell
-28,597
Closed -$6.69M 195
2019
Q2
$6.69M Sell
28,597
-4,744
-14% -$1.1M 0.11% 130
2019
Q1
$7.88M Buy
+33,341
New +$10.5M 0.14% 115
2017
Q1
Sell
-1,077
Closed -$305K 186
2016
Q4
$305K Sell
1,077
-4,562
-81% -$1.35M 0.01% 162
2016
Q3
$1.76M Sell
5,639
-353
-6% -$105K 0.05% 147
2016
Q2
$1.47M Sell
5,992
-3,839
-39% -$1.01M 0.05% 149
2016
Q1
$2.56M Sell
9,831
-400
-4% -$106K 0.09% 140
2015
Q4
$3.13M Buy
+10,231
New +$2.94M 0.12% 124

Other funds holding BIIB

Morningstar Investment Services's BIIB Position: Q3 2024 in Review

Morningstar Investment Services sold out of Biogen (BIIB) in Q3 2024, closing a stake of 1,245 shares — an estimated $285K sold.

Morningstar Investment Services first reported a position in BIIB in Q4 2015 and held it in 21 quarters. The position peaked at $7.88M in Q1 2019. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Morningstar Investment Services reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Morningstar Investment Services sold 1,245 Biogen shares in Q3 2024, an estimated $285K.
  • Morningstar Investment Services first reported a position in Biogen in Q4 2015 and held it in 21 quarters.
  • Morningstar Investment Services's Biogen position peaked at $7.88M in Q1 2019.
  • 916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Morningstar Investment Services's 13F filing for Q3 2024, filed 7 Nov 2024.